Announcements - Search results

Search results: Company announcements for
ANTISENSE THERAPEUTICS LIMITED (ANP)
Released between 01/01/2014 and 31/12/2014

Didn't find the announcement you were after? Search again.

Announcements released as ANP
Date Price sens. Headline
22/12/2014
8:31 AM
asterix Ethics Committee Approves Higher Dose ALT1103 Study
2 pages 121.7KB
09/12/2014
9:39 AM
asterix Company Update
2 pages 39.3KB
21/11/2014
6:53 PM
  Change of Director's Interest Notice RM (amended)
2 pages 22.3KB
21/11/2014
3:04 PM
  Change of Director's Interest Notice (RM)
2 pages 22.3KB
20/11/2014
11:25 AM
  Change of Director's Interest Notice (RM)
2 pages 22.2KB
18/11/2014
3:46 PM
  News Report Misinterprets Substantial Notice
1 page 35.8KB
17/11/2014
4:33 PM
  Change in substantial holding from CIR
4 pages 75.1KB
17/11/2014
9:16 AM
  Change of Director's Interest Notice (RM)
2 pages 22.3KB
12/11/2014
11:45 AM
  Change of Director's Interest Notice (MD)
2 pages 23.2KB
12/11/2014
11:44 AM
  Change of Director's Interest Notice (CB)
2 pages 23.2KB
12/11/2014
11:43 AM
  Change of Director's Interest Notice (GM)
2 pages 23.1KB
12/11/2014
11:42 AM
  Change of Director's Interest Notice (RM)
2 pages 22.7KB
12/11/2014
11:34 AM
  Appendix 3B and Cleansing Notice
11 pages 211.9KB
06/11/2014
12:55 PM
  Results of Meeting
1 page 84.1KB
06/11/2014
9:39 AM
  AGM Presentation
26 pages 3.8MB
06/11/2014
8:35 AM
  Share Purchase Plan Acceptances
1 page 21.9KB
31/10/2014
10:51 AM
  Change of Director's Interest Notice (RM)
2 pages 44.2KB
30/10/2014
1:56 PM
  Share Purchase Plan Closing Tomorrow 31 October 2014
1 page 23.0KB
30/10/2014
9:38 AM
asterix Appendix 4C - quarterly
5 pages 39.8KB
24/10/2014
1:22 PM
asterix ATL1102 for MS FDA Response to Phase IIb Study Plans
1 page 21.1KB
24/10/2014
10:36 AM
  Trading Halt Request
1 page 249.7KB
24/10/2014
9:33 AM
asterix Trading Halt
1 page 136.2KB
20/10/2014
9:10 AM
  Shareholder & Investor Presentation
61 pages 4.2MB
17/10/2014
9:17 AM
  ATL1103 for Acromegaly and ATL1102 for MS
1 page 20.9KB
15/10/2014
9:18 AM
asterix Receipt of $1.14 million R&D Tax Incentive payment
1 page 18.5KB
09/10/2014
9:09 AM
  World Leading Clinical Expert to Present to Shareholders
2 pages 187.7KB
07/10/2014
10:36 AM
  Share Purchase Plan Notice under ASIC CO 09/425
1 page 18.9KB
06/10/2014
12:42 PM
  Notice of Annual General Meeting and Annual Report
86 pages 1.4MB
02/10/2014
4:41 PM
  Share Purchase Plan
11 pages 94.4KB
01/10/2014
3:05 PM
  Placement Appendix 3B and Cleansing Notice
12 pages 442.0KB
26/09/2014
12:49 PM
asterix Share Purchase Plan Underwritten
1 page 22.2KB
25/09/2014
9:40 AM
asterix Placement and Share Purchase Plan
2 pages 73.1KB
23/09/2014
12:33 PM
asterix Trading Halt
2 pages 186.8KB
22/09/2014
9:39 AM
asterix ATL1102 Phase II MS trial results published in NEUROLOGY
2 pages 38.8KB
16/09/2014
9:57 AM
asterix ATL1102 for MS further development plans
2 pages 28.5KB
09/09/2014
9:11 AM
  BRR Interview - CEO Discusses ATL1103 Phase II Trial Results
2 pages 30.9KB
04/09/2014
4:50 PM
  Ceasing to be a substantial holder
1 page 304.3KB
03/09/2014
9:10 AM
asterix ATL1103 Phase II Trial - Successful Efficacy Results
7 pages 326.0KB
01/09/2014
8:45 AM
asterix Trading Halt
2 pages 204.4KB
28/08/2014
12:35 PM
  ATL1103 Acromegaly Phase II Trial Results
2 pages 31.8KB
25/08/2014
9:05 AM
asterix Appendix 4E and Full Year Audited Statutory Accounts
81 pages 2.0MB
19/08/2014
8:58 AM
asterix Strategy Update - ATL1103 & ATL1102
2 pages 28.6KB
31/07/2014
1:04 PM
asterix Appendix 4C - quarterly
6 pages 57.6KB
29/07/2014
9:05 AM
  ATL1103 Acromegaly Phase II Trial Dosing Completed
2 pages 46.4KB
23/07/2014
9:29 AM
asterix ATL1102 for Stem Cell Mobilisation Trial Results
2 pages 31.5KB
07/07/2014
9:56 AM
asterix Allowance of Canadian Patent on ATL1103 & Development Update
2 pages 35.2KB
02/07/2014
1:37 PM
  Change in substantial holding
2 pages 107.7KB
02/06/2014
9:05 AM
asterix Non-dilutive Funding Facility
1 page 20.3KB
23/05/2014
9:07 AM
  Investor Newsletter
6 pages 411.4KB
06/05/2014
9:20 AM
  Updated Investor Presentation
16 pages 677.5KB
29/04/2014
9:37 AM
asterix Appendix 4C - quarterly
5 pages 44.4KB
07/04/2014
9:44 AM
asterix ATL1102 for MS US Patent Allowance Extends IP Position
2 pages 44.9KB
01/04/2014
11:43 AM
asterix ATL1102 for MS Toxicology Study Main Findings
1 page 22.6KB
21/03/2014
9:01 AM
asterix ATL1103 Acromegaly Phase II Trial Recruitment Completed
2 pages 73.2KB
18/03/2014
9:10 AM
asterix ATL1102 for Stem Cell Mobilisation Trial Commencement
3 pages 82.1KB
07/03/2014
9:41 AM
  ANP to Present at ROTH Capital Partners Conference
1 page 65.5KB
24/02/2014
5:41 PM
asterix Half Yearly Report and Accounts
28 pages 5.4MB
28/01/2014
9:05 AM
asterix Appendix 4C - quarterly
5 pages 60.1KB
22/01/2014
8:59 AM
asterix ATL1102 for Stem Cell Mobilisation Trial Approval
1 page 26.8KB
17/01/2014
11:59 AM
  Appendix 3B
10 pages 215.1KB
15/01/2014
9:51 AM
  ANP Presentation at Biotech Showcase 2014
25 pages 1.0MB
08/01/2014
9:22 AM
  ANP Selected to Present at Biotech Showcase 2014
2 pages 30.3KB

Useful Information

Other companies that have used the code 'ANP'

  • AUSTRALIAN PETROLEUM FUND - previously known as
  • BA PETROLEUM EXPLORERS TRUST

view available announcements for this company

Didn't find the announcement you were after? Search again.

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.